University Medical Center Utrecht Reports Findings in Life Science (Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe): Life Science

2022 OCT 21 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Life Science is the subject of a report. According to news reporting originating from Utrecht, Netherlands, by NewsRx correspondents, research stated, “Genetic testing has evolved rapidly over recent years and new developments have the potential to provide insights that could improve the ability to diagnose, treat, and prevent diseases. Information obtained through genetic testing has proven useful in other specialties, such as cardiology and oncology.”

Our news editors obtained a quote from the research from University Medical Center Utrecht, “Nonetheless, a range of barriers impedes techniques, such as whole-exome or whole-genome sequencing, pharmacogenomics, and polygenic risk scoring, from being implemented in psychiatric practice. These barriers may be procedural (e.g., limitations in extrapolating results to the individual level), economic (e.g., perceived relatively elevated costs precluding insurance coverage), or related to clinicians’ knowledge, attitudes, and practices (e.g., perceived unfavorable cost-effectiveness, insufficient understanding of probability statistics, and concerns regarding genetic counseling). Additionally, several ethical concerns may arise (e.g., increased stigma and discrimination through exclusion from health insurance).”

According to the news editors, the research concluded: “Here, we provide an overview of potential barriers for the implementation of genetic testing in psychiatry, as well as an in-depth discussion of strategies to address these challenges.”

For more information on this research see: Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe. Translational Psychiatry, 2022;12(1):442. Translational Psychiatry can be contacted at: Springernature, Campus, 4 Crinan St, London, N1 9XW, England. (Nature Publishing Group - http://www.nature.com/; Translational Psychiatry - http://www.nature.com/tp/)

The news editors report that additional information may be obtained by contacting Marte van der Horst, Dept. of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. Additional authors for this research include Justo Pinzon-Espinosa, Janneke Zinkstok, Jehannine Austin, Cora Aalfs, Albert Batalla, Patrick Sullivan, Jacob Vorstman and Jurjen J. Luykx.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1038/s41398-022-02203-6. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Publisher contact information for the journal Translational Psychiatry is: Springernature, Campus, 4 Crinan St, London, N1 9XW, England.

(Our reports deliver fact-based news of research and discoveries from around the world.)